Clinical Trial of Abluminus DES+ Sirolimus Eluting Stent Versus Everolimus-eluting DES

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 137 participants.

Also called NCT03399994

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 137 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03399994
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Italy (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03399994. Randomized; single masking; primary purpose treatment. Start 2018-05-21 (actual); primary completion 2021-04-15 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clinical Trial of Abluminus DES+ Sirolimus Eluting Stent Versus Everolimus-eluting DES
Condition
Diabetes
Intervention (Device)
device implantation during coronary angioplasty
Lead sponsor
Fondazione Evidence per Attività e Ricerche Cardiovascolari ONLUS (class: other)
Collaborator
Mediolanum Cardio Research (class: other)

Record details

Record id
cardio:ct-nct03399994
Content hash
d7607b93bfb24448a34d734cc424597a78e4ba193bbb8d32dfc08be152baba15